{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:30:55Z","timestamp":1786113055566,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u00e9\u2021\u2018\u00e5\u008d\u017d\u00e5\u00b8\u201a\u00e4\u00b8\u00e5\u00bf\u0192\u00e5\u0152\u00bb\u00e9\u2122\u00a2","award":["2022-3-101"],"award-info":[{"award-number":["2022-3-101"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,9]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Scalp angiosarcoma is a rare malignant vascular tumor with the characteristics of occult early symptoms, no specificity, a high misdiagnosis rate, strong invasion, and poor prognosis. The 5-year survival rate is &lt;30%. The accumulation of rare cases is of great significance for optimizing diagnosis and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 78-year-old man presented with a dark-brown nodule on the top of the head 2 months ago, which progressively enlarged with ulceration, erosion, and easy bleeding. Topical antibiotic therapy was ineffective. Imaging showed a mass with an unclear inferior boundary and rich blood flow (without bone destruction). Dermoscopy showed invasive growth with abnormal blood vessels. The diagnosis was confirmed by pathology and immunohistochemistry (positive for CD31, CD34, and ERG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Angiosarcoma of the scalp was confirmed based on skin pathology and immunohistochemical results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The scalp tumor was surgically removed under general anesthesia, and skin from the thigh was taken for transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Skin necrosis and skull exposure in the graft area after the operation. The patient refused further repair treatment, imaging evaluation, radiotherapy, and chemotherapy, and died of massive hemoptysis 5 months after surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Early identification and standardized comprehensive treatment are the core to improving prognosis. In clinical practice, it is necessary to accumulate rare cases, improve disease cognition, optimize diagnosis and treatment processes, and strengthen treatment compliance management to reduce mortality and improve quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046847","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:00:10Z","timestamp":1767988810000},"page":"e46847","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis, treatment, and prognosis of scalp angiosarcoma: A case report"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7994-8568","authenticated-orcid":false,"given":"Xuefeng","family":"Fu","sequence":"first","affiliation":[{"name":"Department of Dermatology, Jinhua Municipal Central Hospital Medical Group, Jinhua, Zhejiang, China"},{"name":"Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Jinhua Municipal Central Hospital Medical Group, Jinhua, Zhejiang, China"},{"name":"Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Jinhua Municipal Central Hospital Medical Group, Jinhua, Zhejiang, China"},{"name":"Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Jinhua Municipal Central Hospital Medical Group, Jinhua, Zhejiang, China"},{"name":"Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1470-2045(10)70023-1","article-title":"Angiosarcoma.","volume":"11","author":"Young","year":"2010","journal-title":"Lancet Oncol"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/annonc\/mdm381","article-title":"Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases.","volume":"18","author":"Fayette","year":"2007","journal-title":"Ann Oncol"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.anndiagpath.2010.07.012","article-title":"Cutaneous angiosarcoma. Analysis of 434 cases from the Surveillance, Epidemiology, and End Results Program, 1973\u20132007.","volume":"15","author":"Albores-Saavedra","year":"2011","journal-title":"Ann Diagn Pathol"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00256-020-03373-4","article-title":"Angiosarcoma arising in massive localized lymphedema.","volume":"49","author":"Dyroff","year":"2020","journal-title":"Skeletal Radiol"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1038\/bjc.2013.590","article-title":"High-risk features in radiation-associated breast angiosarcomas.","volume":"109","author":"D\u2019Angelo","year":"2013","journal-title":"Br J Cancer"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1007\/s00432-021-03678-4","article-title":"PARP inhibition in UV-associated angiosarcoma preclinical models.","volume":"147","author":"Weidema","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"R7-20260805","first-page":"25","article-title":"Treatment of cutaneous angiosarcoma of the scalp and face in Chinese patients: local experience at a regional hospital in Hong Kong.","volume":"24","author":"Chow","year":"2018","journal-title":"Hong Kong Med J"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/hed.24747","article-title":"Survival outcomes for cutaneous angiosarcoma of the scalp versus face.","volume":"39","author":"Bernstein","year":"2017","journal-title":"Head Neck"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"218","DOI":"10.12788\/cutis.1008","article-title":"An update on cutaneous angiosarcoma diagnosis and treatment.","volume":"113","author":"Richards","year":"2024","journal-title":"Cutis"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"102722","DOI":"10.1016\/j.ctrv.2024.102722","article-title":"Clinical recommendations for treatment of localized angiosarcoma: a consensus paper by the Italian Sarcoma Group.","volume":"126","author":"Palassini","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"e246235","DOI":"10.1001\/jamanetworkopen.2024.6235","article-title":"Incidence and presenting characteristics of angiosarcoma in the US, 2001\u20132020.","volume":"7","author":"Wagner","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R12-20260805","first-page":"e1659","article-title":"Multifocal cutaneous angiosarcoma of the scalp: a challenging reconstructive case managed with skin substitutes.","volume":"5","author":"Messias","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.coc.0000227544.01779.52","article-title":"Cutaneous angiosarcoma.","volume":"29","author":"Mendenhall","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"2050313X20940419","DOI":"10.1177\/2050313X20940419","article-title":"Cutaneous angiosarcoma of the head and neck resembling rosacea: a case report.","volume":"8","author":"Wong","year":"2020","journal-title":"SAGE Open Med Case Rep"},{"key":"R15-20260805","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ad.2017.01.014","article-title":"Cutaneous angiosarcoma: clinical and pathology study of 16 cases.","volume":"108","author":"Requena","year":"2017","journal-title":"Actas Dermosifiliogr"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"20170039","DOI":"10.1259\/bjr.20170039","article-title":"Angiosarcoma: clinical and imaging features from head to toe.","volume":"90","author":"Gaballah","year":"2017","journal-title":"Br J Radiol"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamaoto.2014.3584","article-title":"Angiosarcoma of the scalp and face: the Mayo Clinic experience.","volume":"141","author":"Patel","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamafacial.2014.889","article-title":"Scalp reconstruction: an algorithmic approach and systematic review.","volume":"17","author":"Desai","year":"2015","journal-title":"JAMA Facial Plast Surg"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.coms.2013.02.004","article-title":"Reconstruction of the scalp, calvarium, and frontal sinus.","volume":"25","author":"Sittitavornwong","year":"2013","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.bjps.2019.07.024","article-title":"Anterolateral thigh free flaps for the reconstruction of scalp angiosarcoma - 18-year experience in Chang Gung Memorial Hospital.","volume":"72","author":"Chou","year":"2019","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.21873\/anticanres.16110","article-title":"Definitive radiotherapy using electron beam and intensity-modulated radiotherapy for unresectable angiosarcoma of the scalp.","volume":"42","author":"Okano","year":"2022","journal-title":"Anticancer Res"},{"key":"R22-20260805","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/5584_2018_226","article-title":"Tissue engineered skin substitutes.","volume":"1107","author":"Goodarzi","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"R23-20260805","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/SCS.0b013e3181d8418e","article-title":"Use of dermal regeneration template (Integra) for reconstruction of full-thickness complex oncologic scalp defects.","volume":"21","author":"Khan","year":"2010","journal-title":"J Craniofac Surg"},{"key":"R24-20260805","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/09546634.2018.1530443","article-title":"Skin substitutes for acute and chronic wound healing: an updated review.","volume":"31","author":"Dai","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"R25-20260805","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/09546634.2012.754839","article-title":"Comparison between taxane-based chemotherapy with conventional surgery-based therapy for cutaneous angiosarcoma: a single-center experience.","volume":"25","author":"Fujisawa","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"R26-20260805","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11864-018-0531-3","article-title":"Current and future directions for angiosarcoma therapy.","volume":"19","author":"Florou","year":"2018","journal-title":"Curr Treat Options Oncol"},{"key":"R27-20260805","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1080\/09546634.2021.1968333","article-title":"Development and validation of a prognostic nomogram model in primary cutaneous and subcutaneous soft tissue angiosarcoma.","volume":"33","author":"Mao","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"R28-20260805","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1158\/0008-5472.CAN-09-2068","article-title":"KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors.","volume":"69","author":"Antonescu","year":"2009","journal-title":"Cancer Res"},{"key":"R29-20260805","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11864-021-00858-9","article-title":"Current management of angiosarcoma: recent advances and lessons from the past.","volume":"22","author":"Florou","year":"2021","journal-title":"Curr Treat Options Oncol"},{"key":"R30-20260805","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40425-017-0263-0","article-title":"Angiosarcoma treated successfully with anti-PD-1 therapy: a case report.","volume":"5","author":"Sindhu","year":"2017","journal-title":"J ImmunoTher Cancer"},{"key":"R31-20260805","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1470-2045(22)00392-8","article-title":"Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial.","volume":"23","author":"Somaiah","year":"2022","journal-title":"Lancet Oncol"},{"key":"R32-20260805","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/1878-0261.13744","article-title":"Genomic landscape and preclinical models of angiosarcoma.","volume":"19","author":"Benton","year":"2025","journal-title":"Mol Oncol"},{"key":"R33-20260805","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/biomedicines10030573","article-title":"Current status and future directions of immunotherapies in soft tissue sarcomas.","volume":"10","author":"Kerrison","year":"2022","journal-title":"Biomedicines"},{"key":"R34-20260805","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/vetsci2030270","article-title":"Beta adrenergic signaling: a targetable regulator of angiosarcoma and hemangiosarcoma.","volume":"2","author":"Dickerson","year":"2015","journal-title":"Vet Sci"},{"key":"R35-20260805","doi-asserted-by":"crossref","first-page":"614288","DOI":"10.3389\/fonc.2020.614288","article-title":"Propranolol sensitizes vascular sarcoma cells to doxorubicin by altering lysosomal drug sequestration and drug efflux.","volume":"10","author":"Saha","year":"2020","journal-title":"Front Oncol"},{"key":"R36-20260805","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1158\/1541-7786.MCR-23-1075","article-title":"miR-497 target gene regulatory network in angiosarcoma.","volume":"22","author":"Benton","year":"2024","journal-title":"Mol Cancer Res"},{"key":"R37-20260805","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ccell.2015.10.004","article-title":"Constitutive activation of mTORC1 in endothelial cells leads to the development and progression of lymphangiosarcoma through VEGF autocrine signaling.","volume":"28","author":"Sun","year":"2015","journal-title":"Cancer Cell"},{"key":"R38-20260805","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hed.24554","article-title":"Predisposing factors for poor prognosis of angiosarcoma of the scalp and face: systematic review and meta-analysis.","volume":"39","author":"Shin","year":"2017","journal-title":"Head Neck"},{"key":"R39-20260805","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13023-025-03819-9","article-title":"Clinicopathological features, treatment outcomes, and prognostic factors of angiosarcoma: a 21-year experience at one center.","volume":"20","author":"Fang","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"R40-20260805","doi-asserted-by":"crossref","first-page":"2036361320979216","DOI":"10.1177\/2036361320979216","article-title":"Angiosarcoma: a population-based cancer registry descriptive study of 45 consecutive cases diagnosed between 1979 and 2016.","volume":"12","author":"Colas","year":"2020","journal-title":"Rare Tumors"},{"key":"R41-20260805","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/jjco\/hyad048","article-title":"Current topics and management of head and neck sarcomas.","volume":"53","author":"Kobayashi","year":"2023","journal-title":"Jpn J Clin Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T17:00:54Z","timestamp":1785949254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046847","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"2025-08-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}